A detailed history of Harbour Investments, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Harbour Investments, Inc. holds 73,287 shares of PFE stock, worth $2.17 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
73,287
Previous 64,071 14.38%
Holding current value
$2.17 Million
Previous $1.78 Million 15.36%
% of portfolio
0.07%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$25.26 - $29.6 $232,796 - $272,793
9,216 Added 14.38%
73,287 $2.05 Million
Q1 2024

Jul 22, 2024

BUY
$25.89 - $29.73 $185,035 - $212,480
7,147 Added 12.56%
64,071 $1.78 Million
Q4 2023

Feb 16, 2024

SELL
$26.13 - $33.94 $112,149 - $145,670
-4,292 Reduced 7.01%
56,924 $1.64 Million
Q3 2023

Nov 15, 2023

BUY
$32.09 - $37.51 $112,539 - $131,547
3,507 Added 6.08%
61,216 $2.03 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $16,253 - $18,805
450 Added 0.79%
57,709 $2.12 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $165,634 - $215,632
4,205 Added 7.93%
57,259 $2.34 Million
Q4 2022

Feb 15, 2023

BUY
$41.75 - $54.5 $154,433 - $201,595
3,699 Added 7.49%
53,054 $2.72 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $129,353 - $153,372
2,780 Added 5.97%
49,355 $2.59 Million
Q4 2021

Feb 16, 2022

SELL
$41.32 - $61.25 $3.11 Million - $4.61 Million
-75,187 Reduced 61.75%
46,575 $2.75 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $274,004 - $351,982
-6,981 Reduced 5.42%
121,762 $5.24 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $127,839 - $144,820
3,560 Added 2.84%
128,743 $5.04 Million
Q1 2021

Aug 17, 2021

BUY
$33.49 - $37.77 $3.94 Million - $4.44 Million
117,581 Added 1546.71%
125,183 $4.54 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $254,590 - $287,127
7,602 New
7,602 $275,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.